EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

α‐Ketoglutarate –Dependent KDM6 Histone Demethylases and Interferon‐Stimulated Gene Expression in Lupus

Erica N Montano, Moumita Bose, Lihong Huo, Gantsetseg Tumurkhuu, Gabriela De Los Santos, Brianna Simental, Aleksandr B Stotland, Janet Wei, C Noel Bairey Merz iD, Jo Suda, Gislaine Martins, Sarfaraz Lalani und 7 weitere

Arthritis & Rheumatology · 2024-03 · 76 (3) · 396-410

DOI: 10.1002/art.42724 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Arthritis & Rheumatology, online erschienen am 11.01.2024. Verfasst von Erica N Montano und 18 weiteren Autor:innen. Beteiligte Einrichtung: Kao Autoimmunity Institute and Division of Rheumatology, Cedars-Sinai Medical Center, Los Angeles, CA, USA. Hauptthemen laut MEDLINE: Interferon Type I, Lupus Erythematosus, Systemic. Die Arbeit wurde bisher 42-mal zitiert (Crossref) und nennt 65 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NIAID NIH HHS, NIH HHS, National Institutes of Health.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

We aimed to investigate the hypothesis that interferon (IFN)–stimulated gene (ISG) expression in systemic lupus erythematosus (SLE) monocytes is linked to changes in metabolic reprogramming and epigenetic regulation of ISG expression.

Methods

Monocytes from healthy volunteers and patients with SLE at baseline or following IFNα treatment were analyzed by extracellular flux analysis, proteomics, metabolomics, chromatin immunoprecipitation, and gene expression. The histone demethylases KDM6A/B were inhibited using glycogen synthase kinase J4 (GSK‐J4). GSK‐J4 was tested in pristane and resiquimod (R848) models of IFN‐driven SLE.

Results

SLE monocytes had enhanced rates of glycolysis and oxidative phosphorylation compared to healthy control monocytes, as well as increased levels of isocitrate dehydrogenase and its product, α‐ketoglutarate (α‐KG). Because α‐KG is a required cofactor for histone demethylases KDM6A and KDM6B, we hypothesized that IFNα may be driving “trained immune” responses through altering histone methylation. IFNα priming (day 1) resulted in a sustained increase in the expression of ISGs in primed cells (day 5) and enhanced expression on restimulation with IFNα. Importantly, decreased H3K27 trimethylation was observed at the promoters of ISGs following IFNα priming. Finally, GSK‐J4 (KDM6A/B inhibitor) resulted in decreased ISG expression in SLE patient monocytes, as well as reduced autoantibody production, ISG expression, and kidney pathology in R848‐treated BALB/c mice.

Conclusion

Our study suggests long‐term IFNα exposure alters the epigenetic regulation of ISG expression in SLE monocytes via changes in immunometabolism, a mechanism reflecting trained immunity to type I IFN. Importantly, it opens the possibility that targeting histone‐modifying enzymes, such as KDM6A/B, may reduce IFN responses in SLE. image

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Interferon Type ILupus Erythematosus, SystemicMiceAnimalsHumansKetoglutaric AcidsHistonesEpigenesis, GeneticHistone DemethylasesGene ExpressionJumonji Domain-Containing Histone Demethylases

Substanzen

Ketoglutaric AcidsHistonesInterferon Type IHistone DemethylasesKDM6B protein, humanJumonji Domain-Containing Histone Demethylases

Autor:innen und Institutionen

  • Kao Autoimmunity Institute and Division of Rheumatology, Cedars-Sinai Medical Center, Los Angeles, CA, USA.
  • Smidt Heart Institute, Cedars-Sinai Medical Center, Los Angeles, CA, USA.
  • Smidt Heart Institute and Biomedical Imaging Research Institute, Cedars-Sinai Medical Center, Los Angeles, CA, USA.
  • Department of Biomedical Sciences, Cedars-Sinai Medical Center, Los Angeles, CA, USA.
  • Cedars-Sinai Medical Center and F. Widjaja Inflammatory Bowel Disease Institute, Cedars-Sinai Medical Center, USA.
  • Women's Cancer Research Program at the Samuel Oschin Comprehensive Cancer Center, Cedars-Sinai Medical Center, Los Angeles, CA, USA.

ORCID-Profile: C Noel Bairey Merz, Caroline A Jefferies

Förderung

  • NIAID NIH HHS
  • NIH HHS
  • National Institutes of Health

Zitieren

APA

Montano, E. N., Bose, M., Huo, L., Tumurkhuu, G., De Los Santos, G., Simental, B., Stotland, A. B., Wei, J., Bairey Merz, C. N., Suda, J., Martins, G., Lalani, S., Lawrenson, K., Wang, Y., Parker, S., Venuturupalli, S., Ishimori, M., Wallace, D. J., & Jefferies, C. A. (2024). α‐Ketoglutarate –Dependent KDM6 Histone Demethylases and Interferon‐Stimulated Gene Expression in Lupus. Arthritis & Rheumatology, 76(3), 396-410. https://doi.org/10.1002/art.42724

Vancouver

Montano EN, Bose M, Huo L, Tumurkhuu G, De Los Santos G, Simental B, et al. α‐Ketoglutarate –Dependent KDM6 Histone Demethylases and Interferon‐Stimulated Gene Expression in Lupus. Arthritis & Rheumatology. 2024;76(3):396-410. doi:10.1002/art.42724

BibTeX
@article{Montano2024,
  author = {Montano, Erica N and Bose, Moumita and Huo, Lihong and Tumurkhuu, Gantsetseg and De Los Santos, Gabriela and Simental, Brianna and Stotland, Aleksandr B and Wei, Janet and Bairey Merz, C Noel and Suda, Jo and Martins, Gislaine and Lalani, Sarfaraz and Lawrenson, Kate and Wang, Yizhou and Parker, Sarah and Venuturupalli, Swamy and Ishimori, Mariko and Wallace, Daniel J and Jefferies, Caroline A},
  title = {α‐Ketoglutarate –Dependent KDM6 Histone Demethylases and Interferon‐Stimulated Gene Expression in Lupus},
  journal = {Arthritis & Rheumatology},
  year = {2024},
  volume = {76},
  number = {3},
  pages = {396--410},
  doi = {10.1002/art.42724}
}
Kostenlos starten →